TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination

被引：0
|
作者：
Cheng-Fei Jiang
Yun-Xia Xie
Ying-Chen Qian
Min Wang
Ling-Zhi Liu
Yong-Qian Shu
Xiao-Ming Bai
Bing-Hua Jiang
机构：
[1] Nanjing Medical University,Department of Pathology
[2] Zhengzhou University,The Academy of Medical Sciences
[3] Thomas Jefferson University,Department of Medical Oncology
[4] The First Affiliated Hospital of Nanjing Medical University,Department of Oncology
[5] Thomas Jefferson University,Department of Pathology, Anatomy and Cell Biology
来源：
Cancer Cell International | / 21卷
关键词：
TBX15; miR-152; KIF2C; PKM2; Doxorubicin resistance; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation (vol 12, pg 6865, 2020)
    Yang, Chen
    Li, Qiong
    Chen, Xinan
    Zhang, Zheyu
    Mou, Zezhong
    Ye, Fangdie
    Jin, Shengming
    Jun, Xiang
    Tang, Feng
    Jiang, Haowen
    AGING-US, 2023, 15 (10): : 4563 - 4565
  • [22] METTL14/miR-29c-3p axis drives aerobic glycolysis to promote triple-negative breast cancer progression though TRIM9-mediated PKM2 ubiquitination
    Wu, Hao
    Jiao, Yile
    Guo, Xinyi
    Wu, Zhenru
    Lv, Qing
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (03)
  • [23] Retraction Note to: Linc‑ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR‑124/PTBP1/PKM2 axis
    Chenggang Li
    Zhiming Zhao
    Zhipeng Zhou
    Rong Liu
    Cancer Chemotherapy and Pharmacology, 2022, 89 : 149 - 149
  • [24] Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
    Yi, Xianglan
    Lou, Liping
    Wang, Jun
    Xiong, Jing
    Zhou, Sheng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (05) : 647 - 656
  • [25] Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway
    Xianglan Yi
    Liping Lou
    Jun Wang
    Jing Xiong
    Sheng Zhou
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 647 - 656
  • [26] RETRACTED ARTICLE: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis
    Chenggang Li
    Zhiming Zhao
    Zhipeng Zhou
    Rong Liu
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 1199 - 1207
  • [27] miR-301 regulates the SIRT1/SOX2 pathway via CPEB1 in the breast cancer progression
    Jia, Yanjing
    Zhao, Jie
    Yang, Jinjie
    Shao, Jie
    Cai, Zihao
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 22 : 13 - 26
  • [28] miR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin
    Patel, Nibedita
    Garikapati, Koteswara Rao
    Pandita, Raj K.
    Singh, Dharmender Kumar
    Pandita, Tej K.
    Bhadra, Utpal
    Bhadra, Manika Pal
    SCIENTIFIC REPORTS, 2017, 7
  • [29] An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis
    Matkar, Smita
    Sharma, Paras
    Gao, Shubin
    Gurung, Buddha
    Katona, Bryson W.
    Liao, Jennifer
    Muhammad, Abdul Bari
    Kong, Xiang-Cheng
    Wang, Lei
    Jin, Guanghui
    Dang, Chi V.
    Hua, Xianxin
    CANCER CELL, 2015, 28 (04) : 472 - 485
  • [30] miR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin
    Nibedita Patel
    Koteswara Rao Garikapati
    Raj K. Pandita
    Dharmendra Kumar Singh
    Tej K. Pandita
    Utpal Bhadra
    Manika Pal Bhadra
    Scientific Reports, 7
12345